Cargando…
Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
BACKGROUND: Neuromyelitis optica (NMO) is a severely disabling inflammatory disorder of the central nervous system and is often misdiagnosed as multiple sclerosis (MS). There is increasing evidence that treatment options shown to be beneficial in MS, including interferon-β (IFN-β), are detrimental i...
Autores principales: | Harmel, Jens, Ringelstein, Marius, Ingwersen, Jens, Mathys, Christian, Goebels, Norbert, Hartung, Hans-Peter, Jarius, Sven, Aktas, Orhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301061/ https://www.ncbi.nlm.nih.gov/pubmed/25516429 http://dx.doi.org/10.1186/s12883-014-0247-3 |
Ejemplares similares
-
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013) -
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
por: Metz, Imke, et al.
Publicado: (2016) -
The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013) -
Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
por: Paul, Friedemann, et al.
Publicado: (2007) -
Tumefactive Demyelination Associated with Bilateral Optic Neuritis in Neuromyelitis Optica Spectrum Disorders
por: Verma, Rajesh, et al.
Publicado: (2019)